Before Brands, Menlo Park, CA-based specialists in early childhood allergy prevention, received a minority investment from Nestlé Health Science.
Gurnet Point Capital, a private investment firm focused on healthcare, invested alongside NHSc in this financing and remains a significant minority equity investor in the company.
The amount of the deal was not disclosed.
NHSc has acquired the exclusive licensing rights to Before Brands’ products outside the United States and also has an option to purchase all remaining equity in the company in the future.
Led by Ashley Dombkowski, Ph.D., co-founder and CEO, Before Brands is the inventor of the SpoonfulOneTM line, a line of advanced childhood nutritional products reducing food allergy development risk with 16 key allergens. The core technology is based on research and intellectual property licensed from Stanford University, training the child’s immune system through feeding over months to years.
The proprietary SpoonfulOneTM multi-protein blend was developed by globally recognized pediatric allergist and protein biochemist, Kari Nadeau, M.D., Ph.D., inventor and co-founder, Before Brands.
The products are currently available in the U.S. on www.SpoonfulOne.com and Amazon, and will be available outside the U.S. in the second half of 2020. SpoonfulOneTM also partners with pediatricians across the U.S. who recommend it at four-to-six month well-baby visits.